CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online in ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

Doctors have said there is a risk that weight loss jabs such as Ozempic and Mounjaro could raise the risk of being diagnosed ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

It is not unusual for a man of Biden’s age to skip prostate cancer screening, for a variety of reasons.

The National Comprehensive Cancer Network (NCCN) announces 2025 awardees who go above and beyond to define and advance ...